Portfolio company
biognosys
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Biognosys provides proteomics software, kits, and contract research services to researchers and pharmaceutical companies for large-scale protein identification and quantification using mass spectrometry.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
biocrates
This company produces mass spectrometry kits and software for quantitative metabolomics analysis for pharmaceutical companies, research institutions, and clinical laboratories.
Somalogic
This company provides proteomic analysis services and protein measurement platforms to academic medical centres, pharmaceutical companies and biotechnology organisations for life sciences research.
Range Biotechnologies
This company develops a proteomics platform for high-throughput protein quantification to support pharmaceutical companies and clinical laboratories with drug discovery and diagnostics.
BigOmics Analytics
This company develops self-service software platforms for bioinformaticians and biologists to analyse and visualise transcriptomics and proteomics data within life science organisations.
DC Biosciences
DC Biosciences provides proteomics services and research tools to pharmaceutical and biotechnology companies to support drug discovery and development processes.
Metabolon
This company develops metabolomics profiling kits and analysis services for pharmaceutical, biotechnology, and academic researchers to identify biomarkers and understand biological pathways.
Omivera
This contract research organisation provides a chemical proteomics platform for measuring drug-target engagement in living cells for pharmaceutical and biotechnology partners.
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
